The 20 Best Pulmonary Fibrosis Doctors Near Me in Baltimore, MD

Dr. Danoff is an Assistant Professor in the Division of Pulmonary and Critical Care Medicine and Co-Director of the Hopkins Interstitial Lung Disease Clinic. She is a specialist in diseases causing fibrosis or scarring in the lung, particularly those associated with autoimmune diseases including myositis. Dr. Danoff is rated as an Elite provider by MediFind in the treatment of Pulmonary Fibrosis. Her top areas of expertise are Interstitial Lung Disease, Acute Interstitial Pneumonia, Pulmonary Fibrosis, Lung Transplant, and Endoscopy.

Maureen Horton is an Intensive Care Medicine provider in Baltimore, Maryland. Dr. Horton is rated as an Elite provider by MediFind in the treatment of Pulmonary Fibrosis. Her top areas of expertise are Pulmonary Fibrosis, Acute Interstitial Pneumonia, Interstitial Lung Disease, and Idiopathic Pulmonary Fibrosis.

Dr. Pali Dedhiya Shah is a pulmonary and critical care physician. She is an expert in the diagnosis and treatment of advanced lung disease and lung transplantation. She is the medical director of the Johns Hopkins Lung Transplant program. She is a member of the International Society for Heart and Lung transplantation and provides teaching to medical students, residents and fellows at Johns Hopkins. Dr. Shah earned her medical degree from Jefferson Medical College of Thomas Jefferson University. She completed her residency at the Hospital of the University of Pennsylvania and performed a fellowship in pulmonary and critical care medicine at Johns Hopkins. Dr. Shah joined the Johns Hopkins faculty as an assistant professor of medicine in 2011. Dr. Shah is rated as a Distinguished provider by MediFind in the treatment of Pulmonary Fibrosis. Her top areas of expertise are Pulmonary Fibrosis, Lung Metastases, Acute Interstitial Pneumonia, Interstitial Lung Disease, and Lung Transplant.

My clinical and research interests focus on disorders caused by telomere dysfunction. Our goal is to define approaches to surveillance, diagnosis and treatment for patients with telomere-mediated disease. Human syndromes associated with telomere shortening were first identified in the context of dyskeratosis congenita, a premature aging syndrome that predisposes to cancer. Dyskeratosis congenita patients and patients with telomere-mediated syndromes have an increased risk for developing certain malignancies which include myelodysplastic syndromes, myeloid leukemia and squamous cell carcinomas of the upper aerodigestive tract. The Telomere Clinic at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins provides multi-disciplinary care to patients who are suspected to have or who carry the diagnosis of telomere-related disorders. These disorders include individuals with cancer, bone marrow failure/aplastic anemia, lung disease including idiopathic pulmonary fibrosis and liver cirrhosis, among others. Our clinic brings together geneticists, genetic counselors, and we work closely with expert physicians in adult and pediatric hematology, bone marrow transplant, pulmonary medicine, lung transplant medicine, hepatology, and otolaryngology. Together, our team has established expertise in the management of these disorders and is at the forefront of leading the effort to individualize care for affected patients and their families. My group also has ongoing research efforts which include a long-term study to understand the genetics and spectrum of telomere disorders through a Registry which has been based at Johns Hopkins since 2005. Dr. Armanios is rated as a Distinguished provider by MediFind in the treatment of Pulmonary Fibrosis. Her top areas of expertise are Pulmonary Fibrosis, Primary T Cell Immunodeficiency, Emphysema, and Ataxia-Telangiectasia.

Errol L. Bush, M.D., FACS, is a thoracic surgeon and surgical director of the Advanced Lung Disease and Lung Transplant Program for the Johns Hopkins Comprehensive Transplant Center. He also serves as director of the Ex vivo Lung Perfusion Program (EVLP). Dr. Bush specializes in the surgical treatment of chronic and end stage lung diseases, as well as benign (non-cancerous) and malignant (cancerous) diseases and lesions of the chest. He is skilled in minimally invasive operations such as video-assisted thoracoscopic surgery (VATS), a type of thoracic surgery performed using a small video camera that is introduced into the patient's chest via a scope to treat lung and esophageal cancers. Dr. Bush also has experience with extracorporeal membrane oxygenation (ECMO), a technique of providing both cardiac and respiratory support oxygen to patients whose heart and lungs can no longer serve their function. His research interests include investigations of outcomes and health disparities related to lung cancer, lung transplant and ECMO patients. Dr. Bush is currently leading several open clinical trials. Dr. Bush is rated as an Advanced provider by MediFind in the treatment of Pulmonary Fibrosis. His top areas of expertise are Lung Cancer, Pulmonary Fibrosis, Collapsed Lung, Lung Transplant, and Heart Transplant.

David Kass is a Cardiologist in Baltimore,, Maryland. Dr. Kass is rated as an Advanced provider by MediFind in the treatment of Pulmonary Fibrosis. His top areas of expertise are Heart Failure with Preserved Ejection Fraction (HFpEF), Heart Failure, Pulmonary Hypertension, Pulmonary Fibrosis, and Heart Transplant.

Dr. Wise is a pulmonary, critical care physician. He is an expert in the diagnosis and treatment of patients with obstructive lung disease, including those with asthma and COPD. He is a consultant for patients with scleroderma and interstitial lung disease. He has expertise in pulmonary physiology and lung function testing. Dr. Wise’s research focus is the conduct of multi-center clinical trials in airway diseases and related translational research. Dr. Wise is the co-director of the Pulmonary T32 Multi-disciplinary Training Program in Pulmonary Disease. Dr. Wise is rated as an Advanced provider by MediFind in the treatment of Pulmonary Fibrosis. His top areas of expertise are Systemic Sclerosis (SSc), Interstitial Lung Disease, Acute Interstitial Pneumonia, and Sarcoidosis.

Dr. McCormack is a pulmonary, critical care physician and Associate Director of the Pulmonary & Critical Care Medicine Division. She is an expert in the diagnosis and treatment of patients with obstructive lung disease, including those with asthma and COPD. She has expertise in pulmonary physiology. She serves as the Medical Director of the Johns Hopkins University Pulmonary Function Laboratory and as the Chair of the American Thoracic Society Pulmonary Function Test Committee. She earned her M.D. from Jefferson Medical College of Thomas Jefferson University and her M.H.S. from the Bloomberg School of Public Health. She completed her residency at Thomas Jefferson University Hospital and performed a fellowship in pulmonary and critical care medicine at Johns Hopkins. She was the recipient of the Frederick L. Brancati Excellence in Mentoring Award. She plays an active role in mentoring fellows and junior faculty in the Pulmonary & Critical Care Medicine Division. Dr. Mccormack is rated as an Advanced provider by MediFind in the treatment of Pulmonary Fibrosis. Her top areas of expertise are Chronic Obstructive Pulmonary Disease (COPD), Asthma, Acute Interstitial Pneumonia, Interstitial Lung Disease, and Lung Transplant.

Dr. Jonathan Orens is a professor of medicine at the Johns Hopkins University School of Medicine. His areas of clinical expertise include pulmonary and critical care medicine. He is an internationally recognized expert in lung transplantation. Dr. Orens received his M.D. from the University of Maryland School of Medicine. He completed his residency at the University of Maryland Medical Center and performed a fellowship in pulmonary and critical care medicine at the University of Michigan Hospitals. Dr. Orens joined the Johns Hopkins faculty in 1998. His research interests include clinical outcomes of lung transplantation, chronic allograft rejection and ischemic reperfusion injury. Dr. Orens is rated as an Experienced provider by MediFind in the treatment of Pulmonary Fibrosis. His top areas of expertise are Lung Metastases, Cystic Fibrosis, Secondary Immunodeficiency (SID), Lung Transplant, and Endoscopy.

Paul M. Hassoun, M.D., is professor of medicine at the Johns Hopkins University School of Medicine and the director of the pulmonary hypertension program at Johns Hopkins Hospital. He received his medical degree from the Faculté de Médecine Lariboisière-Saint Louis at the University of Paris, France, completed an internship and residency at Brigham and Women’s Hospital and a fellowship in Pulmonary and Critical Care Medicine at Massachusetts General Hospital, both at Harvard Medical School. He was on faculty in the pulmonary division at New England Medical Center/Tufts University School of Medicine (Tufts-NEMC) in Boston, MA, until 2002 when he joined the division of pulmonary and critical care medicine at Johns Hopkins University. Dr. Hassoun has served or currently serves on numerous American Thoracic Society (ATS) assemblies and committees, including the Pulmonary Circulation Long Range Planning Committee, the Pulmonary Circulation Program Committee (for which he served as chair for 2008-2009), the ATS Scientific Advisory Council, Pulmonary Circulation Leadership Committee, and the American College of Chest Physicians Vascular Steering Committee. He served as the ATS Pulmonary Circulation chair (2011-2012) and on the ATS Publications Policy Committee. He was recently elected president of the Pulmonary Vascular Research Institute (PVRI; 2018-2019). Dr. Hassoun has held numerous editorial activities including serving on the editorial board of the American Journal of Respiratory and Critical Medicine (2010 to present), CHEST (2006-2015) and the European Respiratory Review (2008-2015). He currently serves as associate editor of the European Respiratory Journal (2013-present) and has served as associate editor for the Journal of Clinical Investigation (2017-2022). Dr. Hassoun is rated as an Experienced provider by MediFind in the treatment of Pulmonary Fibrosis. His top areas of expertise are Pulmonary Hypertension, Systemic Sclerosis (SSc), Cerebral Hypoxia, Pulmonary Veno-Occlusive Disease, and Lung Transplant.

Stephen C. Mathai, MD, MHS is an Associate Professor of Medicine and part of the Johns Hopkins Pulmonary Hypertension Program. Dr. Mathai received his undergraduate degree from Rutgers College and medical degree from Jefferson Medical College. He pursued residency training in Internal Medicine at Thomas Jefferson University Hospital, where he also served as Chief Medical Resident. Dr. Mathai came to Johns Hopkins for fellowship training in Pulmonary and Critical Care Medicine. During his 5-year fellowship, he obtained a Masters of Health Science degree from the Johns Hopkins Bloomberg School of Public Health and successfully competed for an individual Ruth L. Kirschstein National Research Service Award. Subsequently, he received a K23 award for his research in pulmonary vascular disease in scleroderma. He currently serves as Co-Principal Investigator for the Johns Hopkins PVDOMICS program supported by the NIH and is principal investigator for a clinical trial of therapy for scleroderma associated pulmonary hypertension supported by the Department of Defense Peer Reviewed Medical Research Program. He is also the Co-Director of the Ann Dana Kusch Multidisciplinary Program for Interstitial Lung Disease and Pulmonary Hypertension. Dr. Mathai has been active in numerous committees and holds several leadership positions in academic societies. He is the current chair of the Pulmonary Vascular Disease Network for the American College of Chest Physicians and has served on the steering committee for this organization for the past 4 years. He has served on several committees for the Pulmonary Circulation Assembly of the American Thoracic Society, including the Program Committee and Nominations Committee. He has organized symposia and delivered presentations related to pulmonary hypertension at numerous international meetings. He is the author of more than 100 publications and has given invited research lectures nationally and internationally. Dr. Mathai is also an active member of patient advocacy organizations. Currently, he is a member of the Scientific Leadership Council of the Pulmonary Hypertension Association where he serves as national chairperson of the Preceptorship Program Planning Committee. He is also a member of the Rare Disease Advisory Panel for the Patient Centered Outcomes Research Institute. Dr. Mathai also serves as the faculty leader of the inpatient pulmonary service, the Carol Johns Service, where he is responsible for the education of the internal medicine housestaff and pulmonary fellows. He has also received the Frederick L. Brancati Award for mentorship from the Department of Medicine at Johns Hopkins. Dr. Mathai is rated as an Experienced provider by MediFind in the treatment of Pulmonary Fibrosis. His top areas of expertise are Pulmonary Hypertension, Systemic Sclerosis (SSc), Pulmonary Veno-Occlusive Disease, Sarcoidosis, and Lung Transplant.

Dr. Merlo is an internist who specializes in pulmonary and critical care medicine. Dr. Merlo also has clinical expertise in the care of patients with cystic fibrosis as well as clinical expertise in the care of patients with advanced lung disease who may require or have undergone lung transplantation. Dr. Merlo holds a joint appointment in epidemiology at the Johns Hopkins Bloomberg School of Public Health. Dr. Merlo attended the College of the Holy Cross and completed medical school and residency training in internal medicine at Georgetown University. He completed both clinical and research fellowships in pulmonary and critical care medicine at Johns Hopkins, and earned his M.P.H. at the Bloomberg School of Public Health. His research interests include outcomes in lung transplantation and cystic fibrosis, HIV-related pulmonary disease, and outcomes in Osler Weber Rendu. Dr. Merlo serves as the Associate Program Director of Scholarship for the Osler Medical Housestaff Training Program. He has contributed numerous scientific papers and book chapters related to cystic fibrosis and lung transplantation, and his awards include the Harry Shwachman Clinical Investigator Award from the Cystic Fibrosis Foundation. Dr. Merlo is rated as an Experienced provider by MediFind in the treatment of Pulmonary Fibrosis. His top areas of expertise are Cystic Fibrosis, Secondary Immunodeficiency (SID), Aspergillosis, Lung Transplant, and Endoscopy.

Dr. Stephen C. Yang is a professor of surgery and medical oncology at Johns Hopkins University School of Medicine and The Johns Hopkins Hospital. In October 2008 he was named the first recipient of The Arthur B. and Patricia B. Modell Professor in Thoracic Surgery. Dr. Yang is an extreme supporter of medical students, being the only surgeon (amongst 20 chosen from the School of Medicine) for the medical student advisory Colleges system, and is the faculty sponsor for the Surgery Interest Group and the Asian Pacific American Medical Student Association. Dr. Yang graduated from Duke University with a B.A. in Chemistry and received his M.D. degree from the Medical College of Virginia. He completed his general surgery residency at the University of Texas Health Science Center at Houston, and finished his cardiothoracic surgery fellowship at the Medical College of Virginia. He also completed a 3 year thoracic surgical oncology research fellowship at the University of Texas M. D. Anderson Cancer Center. He currently serves on the Postgraduate Affairs, Medical School Admissions, Educational Policy, and Curriculum Reform Committees in the Johns Hopkins School of Medicine. He served on numerous national and international committees for these organizations, and is the Taskforce Chair on the Looking to the Future Residency Scholarships for the Society of Thoracic Surgeons He is Editor of Practical Reviews in Chest Medicine and guest editor/ reviewer for numerous peer review journals. He is co-editor of the book Current Therapy in Thoracic and Cardiovascular Surgery, edited the esophageal surgical section in the 2nd edition of Atlas of Gastrointestinal Surgery with John Cameron, M.D., and series editor-in-chief of The Early Diagnosis of Cancer also editing the book volume of The Early Diagnosis of Lung Cancer. In 2001, he and his lung transplant team were featured in the ABC series 24/7 and is currently also being followed in the sequel to that series focusing in on resident and medical student teaching. This series as well as other experiences are still shown on the Discovery Channel. The extensive work in preparing an esophageal cancer patient for surgery on the BBC and the Discovery Channel. Dr. Yang's laboratory research interests include using molecular techniques for lung cancer screening and for molecular staging of micrometastasis to predict recurrence following surgical resection. His clinical practice and research covers the breath of general thoracic surgery in pulmonary and esophageal surgery, video-assisted and robotics thoracic surgery, mediastinal and pleural work, lung volume reduction surgery for emphysema, and work in geriatric thoracic surgery. Dr. Yang is rated as an Experienced provider by MediFind in the treatment of Pulmonary Fibrosis. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Lung Nodules, Endoscopy, and Thymectomy.

Michelle Petri, M.D. is a Professor of Medicine at the Johns Hopkins University School of Medicine. She attended medical school at Harvard University and fulfilled her internal medicine residency at the Massachusetts General Hospital. In addition, she completed two fellowship programs at the University of California, San Francisco in allergy and immunology and rheumatology. Dr. Petri is the Director of the Hopkins Lupus Cohort, a longitudinal study of morbidity and mortality in systemic lupus erythematosus, and Co-Director of the Hopkins Lupus Pregnancy Center. Dr. Petri is rated as an Experienced provider by MediFind in the treatment of Pulmonary Fibrosis. Her top areas of expertise are Lupus Nephritis, Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE), Tenotomy, and Osteotomy.

Dr. Lechtzin is a pulmonary and critical care medicine physician. He directs the Adult CF program and the neuromuscular pulmonary clinic at Johns Hopkins and is an expert in the treatment of cystic fibrosis, pulmonary complications of neuromuscular disease and the care of critically ill patients in the Medical ICU. He is a member of the Longcope Firm Faculty and provides teaching to medical students and residents at Johns Hopkins. Dr. Lechtzin is rated as an Experienced provider by MediFind in the treatment of Pulmonary Fibrosis. His top areas of expertise are Cystic Fibrosis, Secondary Immunodeficiency (SID), Newborn Jaundice, Lung Transplant, and Endoscopy.

Nevins Todd is an Intensive Care Medicine provider in Baltimore, Maryland. Dr. Todd is rated as an Advanced provider by MediFind in the treatment of Pulmonary Fibrosis. His top areas of expertise are Interstitial Lung Disease, Acute Interstitial Pneumonia, Pneumonia, Sarcoidosis, and Endoscopy.

Irfan Shafique is a Radiologist in Baltimore, Maryland. Dr. Shafique is rated as an Advanced provider by MediFind in the treatment of Pulmonary Fibrosis. His top areas of expertise are Pulmonary Fibrosis, Emphysema, Lung Nodules, and Chronic Rhinosinusitis with Nasal Polyps (CRSwNP).

Nirav Shah is an Intensive Care Medicine provider in Baltimore, Maryland. Dr. Shah is rated as an Advanced provider by MediFind in the treatment of Pulmonary Fibrosis. His top areas of expertise are Interstitial Lung Disease, Acute Interstitial Pneumonia, Sarcoidosis, Endoscopy, and Gastrostomy.

Jeffrey Galvin is a Pulmonary Medicine provider in Baltimore, Maryland. Dr. Galvin is rated as an Advanced provider by MediFind in the treatment of Pulmonary Fibrosis. His top areas of expertise are Pleurisy, Pleural Effusion, Pneumomediastinum, and Interstitial Lung Disease.

Bradley Maron is a Cardiologist in Baltimore,, Maryland. Dr. Maron is rated as an Experienced provider by MediFind in the treatment of Pulmonary Fibrosis. His top areas of expertise are Pulmonary Hypertension, Hypertension, Heart Failure, Hypertrophic Cardiomyopathy (HCM), and Heart Transplant.